DNA Chip Research Inc.
DNA Chip Research Inc. (2397.T) Stock Competitors & Peer Comparison
See (2397.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2397.T | ¥1,092.00 | +0.18% | 7.4B | -59.64 | -¥18.31 | N/A |
| 4544.T | ¥3,191.00 | -1.02% | 182.8B | 66.13 | ¥48.65 | +3.49% |
| 4694.T | ¥4,045.00 | -1.34% | 152.2B | 22.28 | ¥182.21 | +2.66% |
| 2395.T | ¥1,414.00 | -1.26% | 59.1B | 12.69 | ¥111.84 | +3.09% |
| 2309.T | ¥2,644.00 | +0.46% | 44.6B | 8.48 | ¥311.89 | N/A |
| 4671.T | ¥2,610.00 | -1.02% | 25.9B | 13.92 | ¥186.23 | +4.33% |
| 3386.T | ¥1,261.00 | +0.40% | 7.1B | 21.12 | ¥59.28 | +3.59% |
| 9776.T | ¥1,952.00 | -0.41% | 6.1B | 0.00 | ¥27,381,640.00 | +1.18% |
| 7707.T | ¥204.00 | -7.27% | 5.7B | -160.77 | -¥1.30 | N/A |
| 6090.T | ¥683.00 | -4.34% | 3.9B | 19.67 | ¥35.63 | +2.14% |
Stock Comparison
2397.T vs 4544.T Comparison April 2026
2397.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2397.T stands at 7.4B. In comparison, 4544.T has a market cap of 182.8B. Regarding current trading prices, 2397.T is priced at ¥1,092.00, while 4544.T trades at ¥3,191.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2397.T currently has a P/E ratio of -59.64, whereas 4544.T's P/E ratio is 66.13. In terms of profitability, 2397.T's ROE is -0.05%, compared to 4544.T's ROE of +0.04%. Regarding short-term risk, 2397.T is less volatile compared to 4544.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2397.T.Check 4544.T's competition here